Chapter/Section Purchase

Leave This Empty:

Global Wearable Injectors Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Wearable Injectors Product Introduction
1.2 Market by Type
1.2.1 Global Wearable Injectors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Wearable Injectors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Infectious Disease
1.3.4 Autoimmune Disorder
1.3.5 Cardiovascular Disease
1.3.6 Blood Disorder
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Wearable Injectors Sales Estimates and Forecasts 2017-2028
2.2 Global Wearable Injectors Revenue Estimates and Forecasts 2017-2028
2.3 Global Wearable Injectors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Wearable Injectors Sales by Region
2.4.1 Global Wearable Injectors Sales by Region (2017-2022)
2.4.2 Global Sales Wearable Injectors by Region (2023-2028)
2.5 Global Wearable Injectors Revenue by Region
2.5.1 Global Wearable Injectors Revenue by Region (2017-2022)
2.5.2 Global Wearable Injectors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Wearable Injectors Sales by Manufacturers
3.1.1 Global Top Wearable Injectors Manufacturers by Sales (2017-2022)
3.1.2 Global Wearable Injectors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Wearable Injectors in 2021
3.2 Global Wearable Injectors Revenue by Manufacturers
3.2.1 Global Wearable Injectors Revenue by Manufacturers (2017-2022)
3.2.2 Global Wearable Injectors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Wearable Injectors Revenue in 2021
3.3 Global Wearable Injectors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Wearable Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Wearable Injectors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Wearable Injectors Sales by Type
4.1.1 Global Wearable Injectors Historical Sales by Type (2017-2022)
4.1.2 Global Wearable Injectors Forecasted Sales by Type (2023-2028)
4.1.3 Global Wearable Injectors Sales Market Share by Type (2017-2028)
4.2 Global Wearable Injectors Revenue by Type
4.2.1 Global Wearable Injectors Historical Revenue by Type (2017-2022)
4.2.2 Global Wearable Injectors Forecasted Revenue by Type (2023-2028)
4.2.3 Global Wearable Injectors Revenue Market Share by Type (2017-2028)
4.3 Global Wearable Injectors Price by Type
4.3.1 Global Wearable Injectors Price by Type (2017-2022)
4.3.2 Global Wearable Injectors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Wearable Injectors Sales by Application
5.1.1 Global Wearable Injectors Historical Sales by Application (2017-2022)
5.1.2 Global Wearable Injectors Forecasted Sales by Application (2023-2028)
5.1.3 Global Wearable Injectors Sales Market Share by Application (2017-2028)
5.2 Global Wearable Injectors Revenue by Application
5.2.1 Global Wearable Injectors Historical Revenue by Application (2017-2022)
5.2.2 Global Wearable Injectors Forecasted Revenue by Application (2023-2028)
5.2.3 Global Wearable Injectors Revenue Market Share by Application (2017-2028)
5.3 Global Wearable Injectors Price by Application
5.3.1 Global Wearable Injectors Price by Application (2017-2022)
5.3.2 Global Wearable Injectors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Wearable Injectors Market Size by Type
6.1.1 North America Wearable Injectors Sales by Type (2017-2028)
6.1.2 North America Wearable Injectors Revenue by Type (2017-2028)
6.2 North America Wearable Injectors Market Size by Application
6.2.1 North America Wearable Injectors Sales by Application (2017-2028)
6.2.2 North America Wearable Injectors Revenue by Application (2017-2028)
6.3 North America Wearable Injectors Market Size by Country
6.3.1 North America Wearable Injectors Sales by Country (2017-2028)
6.3.2 North America Wearable Injectors Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Wearable Injectors Market Size by Type
7.1.1 Europe Wearable Injectors Sales by Type (2017-2028)
7.1.2 Europe Wearable Injectors Revenue by Type (2017-2028)
7.2 Europe Wearable Injectors Market Size by Application
7.2.1 Europe Wearable Injectors Sales by Application (2017-2028)
7.2.2 Europe Wearable Injectors Revenue by Application (2017-2028)
7.3 Europe Wearable Injectors Market Size by Country
7.3.1 Europe Wearable Injectors Sales by Country (2017-2028)
7.3.2 Europe Wearable Injectors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Wearable Injectors Market Size by Type
8.1.1 Asia Pacific Wearable Injectors Sales by Type (2017-2028)
8.1.2 Asia Pacific Wearable Injectors Revenue by Type (2017-2028)
8.2 Asia Pacific Wearable Injectors Market Size by Application
8.2.1 Asia Pacific Wearable Injectors Sales by Application (2017-2028)
8.2.2 Asia Pacific Wearable Injectors Revenue by Application (2017-2028)
8.3 Asia Pacific Wearable Injectors Market Size by Region
8.3.1 Asia Pacific Wearable Injectors Sales by Region (2017-2028)
8.3.2 Asia Pacific Wearable Injectors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Wearable Injectors Market Size by Type
9.1.1 Latin America Wearable Injectors Sales by Type (2017-2028)
9.1.2 Latin America Wearable Injectors Revenue by Type (2017-2028)
9.2 Latin America Wearable Injectors Market Size by Application
9.2.1 Latin America Wearable Injectors Sales by Application (2017-2028)
9.2.2 Latin America Wearable Injectors Revenue by Application (2017-2028)
9.3 Latin America Wearable Injectors Market Size by Country
9.3.1 Latin America Wearable Injectors Sales by Country (2017-2028)
9.3.2 Latin America Wearable Injectors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Wearable Injectors Market Size by Type
10.1.1 Middle East and Africa Wearable Injectors Sales by Type (2017-2028)
10.1.2 Middle East and Africa Wearable Injectors Revenue by Type (2017-2028)
10.2 Middle East and Africa Wearable Injectors Market Size by Application
10.2.1 Middle East and Africa Wearable Injectors Sales by Application (2017-2028)
10.2.2 Middle East and Africa Wearable Injectors Revenue by Application (2017-2028)
10.3 Middle East and Africa Wearable Injectors Market Size by Country
10.3.1 Middle East and Africa Wearable Injectors Sales by Country (2017-2028)
10.3.2 Middle East and Africa Wearable Injectors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Becton
11.1.1 Becton Corporation Information
11.1.2 Becton Overview
11.1.3 Becton Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Becton Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Becton Recent Developments
11.2 Dickinson and Company
11.2.1 Dickinson and Company Corporation Information
11.2.2 Dickinson and Company Overview
11.2.3 Dickinson and Company Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Dickinson and Company Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Dickinson and Company Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Overview
11.3.3 Medtronic Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Medtronic Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medtronic Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Johnson & Johnson Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Johnson & Johnson Recent Developments
11.5 Insulet Corporation
11.5.1 Insulet Corporation Corporation Information
11.5.2 Insulet Corporation Overview
11.5.3 Insulet Corporation Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Insulet Corporation Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Insulet Corporation Recent Developments
11.6 Unilife Corporation
11.6.1 Unilife Corporation Corporation Information
11.6.2 Unilife Corporation Overview
11.6.3 Unilife Corporation Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Unilife Corporation Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Unilife Corporation Recent Developments
11.7 Enable Injections
11.7.1 Enable Injections Corporation Information
11.7.2 Enable Injections Overview
11.7.3 Enable Injections Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Enable Injections Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Enable Injections Recent Developments
11.8 SteadyMed
11.8.1 SteadyMed Corporation Information
11.8.2 SteadyMed Overview
11.8.3 SteadyMed Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 SteadyMed Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 SteadyMed Recent Developments
11.9 Ypsomed Group
11.9.1 Ypsomed Group Corporation Information
11.9.2 Ypsomed Group Overview
11.9.3 Ypsomed Group Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ypsomed Group Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ypsomed Group Recent Developments
11.10 West Pharmaceutical Services
11.10.1 West Pharmaceutical Services Corporation Information
11.10.2 West Pharmaceutical Services Overview
11.10.3 West Pharmaceutical Services Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 West Pharmaceutical Services Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 West Pharmaceutical Services Recent Developments
11.11 Unilife
11.11.1 Unilife Corporation Information
11.11.2 Unilife Overview
11.11.3 Unilife Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Unilife Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Unilife Recent Developments
11.12 CeQur
11.12.1 CeQur Corporation Information
11.12.2 CeQur Overview
11.12.3 CeQur Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 CeQur Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CeQur Recent Developments
11.13 Sensile Medical
11.13.1 Sensile Medical Corporation Information
11.13.2 Sensile Medical Overview
11.13.3 Sensile Medical Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sensile Medical Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sensile Medical Recent Developments
11.14 BD Medical
11.14.1 BD Medical Corporation Information
11.14.2 BD Medical Overview
11.14.3 BD Medical Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 BD Medical Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 BD Medical Recent Developments
11.15 Roche
11.15.1 Roche Corporation Information
11.15.2 Roche Overview
11.15.3 Roche Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Roche Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Roche Recent Developments
11.16 ScPharmaceuticals
11.16.1 ScPharmaceuticals Corporation Information
11.16.2 ScPharmaceuticals Overview
11.16.3 ScPharmaceuticals Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 ScPharmaceuticals Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 ScPharmaceuticals Recent Developments
11.17 SteadyMed
11.17.1 SteadyMed Corporation Information
11.17.2 SteadyMed Overview
11.17.3 SteadyMed Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 SteadyMed Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 SteadyMed Recent Developments
11.18 J & J
11.18.1 J & J Corporation Information
11.18.2 J & J Overview
11.18.3 J & J Wearable Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 J & J Wearable Injectors Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 J & J Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Wearable Injectors Industry Chain Analysis
12.2 Wearable Injectors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Wearable Injectors Production Mode & Process
12.4 Wearable Injectors Sales and Marketing
12.4.1 Wearable Injectors Sales Channels
12.4.2 Wearable Injectors Distributors
12.5 Wearable Injectors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Wearable Injectors Industry Trends
13.2 Wearable Injectors Market Drivers
13.3 Wearable Injectors Market Challenges
13.4 Wearable Injectors Market Restraints
14 Key Findings in The Global Wearable Injectors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer